Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations

Minami Ohara, Yasuhiko Suzuki, Saki Shinohara, Inna Y. Gong, Crystal L. Schmerk, Rommel G. Tirona, Ute I. Schwarz, Ming Shien Wen, Ming Ta Michael Lee, Kiyoshi Mihara, Edith A. Nutescu, Minoli A. Perera, Larisa H. Cavallari, Richard B. Kim, Harumi Takahashi*

*Corresponding author for this work

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Background: Population differences in warfarin dosing requirement have been reported; however, unlike the pharmacokinetics (PK) of warfarin, the quantitative influences of pharmacodynamic (PD) factors on the anticoagulation response to warfarin in different ethnic populations are totally unknown. Methods: Using population PK/PD analysis, we attempted to identify predictors of S-warfarin clearance [CL(S)] and half maximal effective concentration (EC50) to quantify racial differences in both PK and PD parameters, and to assess the contribution of these parameters to the international normalized ratio (INR) and over-anticoagulation response (INR ≥ 4) in a cohort of 309 White, Asian and African American patients. Results: Similar to our previous findings, the median CL(S) was 30% lower in African American patients than Asian and White patients (169 vs. 243 and 234 mL/h, p < 0.01). EC50 showed a greater racial difference than CL(S) [1.03, 1.70 and 2.76 μg/mL for Asian, White and African American patients, respectively, p < 0.01). Significant predictors of INR included demographic/clinical (age, body weight, creatinine clearance and sex) and genotypic (CYP2C9*3,*8 and VKORC1 −1639G>A) factors, as well as African American ethnicity. In all three racial groups, genetic predictors of INR appeared to have greater influence than demographic/clinical predictors. Both CL(S) and EC50 contributed to the over-anticoagulation response to warfarin. Patients having VKORC1 −1639 G>A and/or factors associated with reduced CYP2C9 activity were more likely to have an INR ≥ 4. Conclusions: Although there were contrasting racial differences in CL(S) and EC50 that impacted on the INR, the racial difference in EC50 was greater than that for CL(S), thus explaining the higher warfarin requirement for African American patients.

Original languageEnglish (US)
Pages (from-to)1077-1089
Number of pages13
JournalClinical Pharmacokinetics
Volume58
Issue number8
DOIs
StatePublished - Aug 1 2019

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations'. Together they form a unique fingerprint.

  • Cite this

    Ohara, M., Suzuki, Y., Shinohara, S., Gong, I. Y., Schmerk, C. L., Tirona, R. G., Schwarz, U. I., Wen, M. S., Lee, M. T. M., Mihara, K., Nutescu, E. A., Perera, M. A., Cavallari, L. H., Kim, R. B., & Takahashi, H. (2019). Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations. Clinical Pharmacokinetics, 58(8), 1077-1089. https://doi.org/10.1007/s40262-019-00745-5